Experts discuss the metrics used to evaluate continuous glucose monitoring (CGM)'s comprehensive return on investment, including both cost savings and quality measure performance, and identify which patient populations demonstrate the strongest combined benefits in costs, quality measures, and outcomes, along with how these groups are prioritized for CGM access.
Video content above is prompted by the following:
Historically Redlined Areas Face Inequities in Rapid EMS Care Access
August 5th 2025Residents in historically redlined grade D areas were 1.67 times more likely to have no rapid access to EMS than in grade A areas, increasing their hazard risk of injury-related morbidity and mortality.
Read More